Sequenom, Inc.
Sequenom is an established genomic analysis company with two principal divisions: genetic analysis systems and reagents, and noninvasive prenatal diagnostics. As an industry innovator in DNA detection technology, Sequenom's benchtop MassARRAY Compact system allows a direct mass measurement of nucleic acids, providing unparalleled precision and quantitation. The MassARRAY system is a multi-application MALDI-TOF MS platform for genotyping, methylation and quantitative gene expression analysis. Sequenom continues to refine these core applications and has developed several new applications for copy number variation analysis and comparative sequence analysis for bacteria and viruses. On the diagnostics front, Sequenom is developing a comprehensive portfolio of prenatal test methods by combining the versatility of the MassARRAY system with the Company's SEQureDxtrade mark technology, which enables the detection of circulating cell-free fetal nucleic acids in a maternal blood sample.
Cullinan
Amy
A
Sequenom, Inc., 3595 John Hopkins Ct., San Diego, CA 92121, USA.
Cantor
Charles
C
D001709:Biotechnology / Q000295:instrumentation* / Q000379:methods* / Q000639:trends; D005820:Genetic Testing / Q000379:methods / Q000639:trends; D023281:Genomics / Q000295:instrumentation / Q000379:methods / Q000639:trends; D006801:Humans; D020641:Polymorphism, Single Nucleotide / Q000235:genetics; D011296:Prenatal Diagnosis / Q000295:instrumentation / Q000379:methods / Q000639:trends; D019032:Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization / Q000295:instrumentation / Q000379:methods / Q000639:trends